Evidence map›Paper›PMID 20304670›Full record

ReviewTrends in endocrinology and metabolism: TEM2010

Immune surveillance of the maternal/fetal interface: controversies and implications.

Adrian Erlebacher

Abstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Endometrial Microbiota and Immune Tolerance in Pregnancy.International journal of molecular sciences · 2023
    Review
  2. Article
  3. The Natural Course ofMicroorganisms · 2021
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Dendritic cell function at the maternal-fetal interface.Expert review of clinical immunology · 2011
    Article
  20. Hormonal evidence supports the theory of selection in utero.American journal of human biology : the official journal of the Human Biology Council
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Adrian ErlebacherNew York University School of Medicine, New York, NY, USA. Adrian.Erlebacher@nyumc.org

Funding

Dendritic cell behavior at the maternal/fetal interfaceR01AI062980 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ERLEBACHER, ADRIAN · 2005 to 2009
$1.9M
NIAID NIH HHS R01 AI062980NIAID NIH HHS R01-AI062980
6 · The paper itself

Abstract

How the fetal 'allograft' avoids rejection during pregnancy remains a major unresolved immunological paradox. Recent work has suggested that fetomaternal tolerance is in fact maintained by a number of redundant mechanisms, but their relative importance has remained poorly defined. In this paper, I discuss an emerging controversy regarding the ability of maternal T cells to mediate fetal rejection at a time when they appear to be ignorant of fetal and placental antigens. This paradox within a paradox highlights two major research directions in the field of reproductive immunology that, when ultimately reconciled, promise to give significant insight into mechanisms of impaired fertility and compromised fetal and maternal health.

Indexed as

AnimalsFemaleImmune ToleranceImmunologic SurveillanceMaleMaternal-Fetal ExchangeMicePlacentaPregnancy

Identifiers

PMID20304670
PMCPMC2892024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.